Blake Borgeson sold $155K of RXRX stock

Blake Borgeson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 40,000 shares of RXRX stock worth $155K, per an SEC Form 4 filed Nov 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 3, 2026, 1 day before it was made public.

RXRX has moved -4.3% since the trade date, from $3.68 to $3.52 (Nov 6, 2026 close).